Caseware UK (AP4) 2024.0.164 2024.0.164 2025-02-282025-02-28false2024-03-01falseNo description of principal activity33trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 03823303 2024-03-01 2025-02-28 03823303 2023-03-01 2024-02-29 03823303 2025-02-28 03823303 2024-02-29 03823303 c:Director1 2024-03-01 2025-02-28 03823303 d:CurrentFinancialInstruments 2025-02-28 03823303 d:CurrentFinancialInstruments 2024-02-29 03823303 c:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 03823303 c:FullAccounts 2024-03-01 2025-02-28 03823303 c:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 03823303 c:Micro-entities 2024-03-01 2025-02-28 03823303 e:PoundSterling 2024-03-01 2025-02-28 iso4217:GBP xbrli:pure
Registered number: 03823303


OSTEOCARE IMPLANT SYSTEM LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 28 FEBRUARY 2025




 
OSTEOCARE IMPLANT SYSTEM LIMITED
REGISTERED NUMBER: 03823303

BALANCE SHEET
AS AT 28 FEBRUARY 2025

28 February
29 February
2025
2024
£
£


Fixed assets
12,445
16,593

Current assets
589,367
648,541

Creditors: amounts falling due within one year
(35,102)
(31,417)

Net current assets
 
 
554,265
 
 
617,124

Total assets less current liabilities
566,710
633,717


Net assets
566,710
633,717



Capital and reserves
566,710
633,717


Notes


General information

The company is a private limited company, having a share capital, registered in England and Wales, company
registration number 03823303. The registered office is situated at c/o CWM, 1a High Street, Epsom, Surrey KT19 8DA.


Average number of employees

The average monthly number of employees, including directors, during the year was 3 (2024 - 3).

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 8 September 2025.






Page 1

 
OSTEOCARE IMPLANT SYSTEM LIMITED
REGISTERED NUMBER: 03823303
    
BALANCE SHEET (CONTINUED)
AS AT 28 FEBRUARY 2025

C A Gauld
Director

 
Page 2